• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) Back to Search Results
Model Number G125
Device Problems Signal Artifact/Noise (1036); High impedance (1291); Over-Sensing (1438); Pacing Problem (1439); Inaccurate Synchronization (1609); High Capture Threshold (3266)
Patient Problem Ventricular Fibrillation (2130)
Event Date 01/18/2024
Event Type  Injury  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) oversensed noisy signals on the right ventricular (rv) channel that led to inappropriate anti-tachycardia pacing (atp) and shock therapy.The rv lead is a non-boston scientific product.The second round of atp induced the patient into ventricular fibrillation (vf).A shock converted the patient back to a normal sinus rhythm.However, noisy signals were still present with oversensing.It was noted that there was a total of 29 episodes with the noisy signals since approximately a week before the call.The device exhibited a rise in impedance but remained within range and a rise in capture thresholds.The device was explanted and upgraded to a subcutaneous implantable cardioverter defibrillator (s-icd).No additional adverse patient effects were reported.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) oversensed noisy signals on the right ventricular (rv) channel that led to inappropriate anti-tachycardia pacing (atp) and shock therapy.The rv lead is a non-boston scientific product.The second round of atp induced the patient into ventricular fibrillation (vf).A shock converted the patient back to a normal sinus rhythm.However, noisy signals were still present with oversensing.It was noted that there was a total of 29 episodes with the noisy signals since approximately a week before the call.The device exhibited a rise in impedance but remained within range and a rise in capture thresholds.The device was explanted and upgraded to a subcutaneous implantable cardioverter defibrillator (s-icd).No additional adverse patient effects were reported.Additional information received indicates that this device is still implanted, however, it is programmed off.No additional adverse patient effects were reported.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) oversensed noisy signals on the right ventricular (rv) channel that led to inappropriate anti-tachycardia pacing (atp) and shock therapy.The rv lead is a non-boston scientific product.The second round of atp induced the patient into ventricular fibrillation (vf).A shock converted the patient back to a normal sinus rhythm.However, noisy signals were still present with oversensing.It was noted that there was a total of 29 episodes with the noisy signals since approximately a week before the call.The device exhibited a rise in impedance but remained within range and a rise in capture thresholds.The device was explanted and upgraded to a subcutaneous implantable cardioverter defibrillator (s-icd).No additional adverse patient effects were reported.Additional information received indicates that this device is still implanted, however, it is programmed off.No additional adverse patient effects were reported.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.The associated investigation determined that this device exhibited intermittent impedance measurements with no conclusive evidence of a product performance issue or inadequate lead-to-device connection; please refer to the description for more information regarding the specific circumstances of this event.Investigation has determined that this type of event is likely the result of an intermittent high impedance condition associated with the device spring contact and lead terminal ring.A design enhancement was implemented in 2020 to stabilize the electrical connection between the spring contact and the lead terminal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18652214
MDR Text Key334681451
Report Number2124215-2024-06585
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 02/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberG125
Device Catalogue NumberG125
Device Lot Number157618
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/23/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age59 YR
Patient SexFemale
-
-